Contributors

Phyllis Wise has spent more than 30 years trying to understand the role of estrogen in animal models, and found that the hormone protected the body from injury following stroke. So, in 2002, when the Women's Health Initiative announced that hormone therapy appeared to cause more harm than good, Wise, based at the University of Washington, and her colleagues were shocked. Wise and her

Written byThe Scientist
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Phyllis Wise has spent more than 30 years trying to understand the role of estrogen in animal models, and found that the hormone protected the body from injury following stroke. So, in 2002, when the Women's Health Initiative announced that hormone therapy appeared to cause more harm than good, Wise, based at the University of Washington, and her colleagues were shocked. Wise and her colleagues returned to their animal models, and discovered that the clinical trial failed to tell the whole story (see "Clearing Estrogen's Bad Name"). Basic and clinical scientists "need to talk with each other," she says, "so that clinical work is based upon what we know from animal models and clinical studies are carried back to [basic scientist] investigators."

In this month's Opinion, on "Disease Prevention in Islamic Countries", Ali Ardalan, an epidemiologist and assistant professor in Tehran, Iran, and coauthors representing several Islamic countries, argue that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies